Cargando…

Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry

BACKGROUND: We previously identified two hydrolyzable tannins, chebulagic acid (CHLA) and punicalagin (PUG) that blocked herpes simplex virus type 1 (HSV-1) entry and spread. These compounds inhibited viral glycoprotein interactions with cell surface glycosaminoglycans (GAGs). Based on this property...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Liang-Tzung, Chen, Ting-Ying, Lin, Song-Chow, Chung, Chueh-Yao, Lin, Ta-Chen, Wang, Guey-Horng, Anderson, Robert, Lin, Chun-Ching, Richardson, Christopher D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750913/ https://www.ncbi.nlm.nih.gov/pubmed/23924316 http://dx.doi.org/10.1186/1471-2180-13-187

Ejemplares similares

Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL(pro)
por: Du, Ruikun, et al.
Publicado: (2021)

(4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry
por: Chung, Chueh-Yao, et al.
Publicado: (2016)

Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry
por: Kuo, Yu-Ting, et al.
Publicado: (2020)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses
por: Lu, Shengsheng, et al.
Publicado: (2021)

Ferroptosis-Inhibitory Difference between Chebulagic Acid and Chebulinic Acid Indicates Beneficial Role of HHDP
por: Yang, Lin, et al.
Publicado: (2021)

Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors
por: Li, Ping, et al.
Publicado: (2020)

Chebulagic Acid, a Hydrolyzable Tannin, Exhibited Antiviral Activity in Vitro and in Vivo against Human Enterovirus 71
por: Yang, Yajun, et al.
Publicado: (2013)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)

Modified cyclodextrins as broad-spectrum antivirals
por: Jones, Samuel T., et al.
Publicado: (2020)

Punicalagin Regulates Signaling Pathways in Inflammation-Associated Chronic Diseases
por: Xu, Jie, et al.
Publicado: (2021)

Physiological and Immune Functions of Punicalagin
por: Venusova, Eva, et al.
Publicado: (2021)

MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation
por: Lin, Ren-Jye, et al.
Publicado: (2013)

Anti-Hyperglycemic Effect of Chebulagic Acid from the Fruits of Terminalia chebula Retz
por: Huang, Yi-Na, et al.
Publicado: (2012)

Inhibition of Angiogenesis In Vitro by Chebulagic Acid: A COX-LOX Dual Inhibitor
por: Athira, A. P., et al.
Publicado: (2013)

Broad-spectrum antivirals against viral fusion
por: Vigant, Frederic, et al.
Publicado: (2015)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022)

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2
por: Groß, Rüdiger, et al.
Publicado: (2022)

Antiviral Natural Products and Herbal Medicines
por: Lin, Liang-Tzung, et al.
Publicado: (2014)

Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
por: Soto-Acosta, Ruben, et al.
Publicado: (2021)

Punicalagin Targets Atherosclerosis: Gene Expression Profiling of THP-1 Macrophages Treated with Punicalagin and Molecular Docking
por: Huwait, Etimad, et al.
Publicado: (2022)

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway
por: Zhao, Jing, et al.
Publicado: (2023)

The broad-spectrum antiviral functions of IFIT and IFITM proteins
por: Diamond, Michael S., et al.
Publicado: (2012)

Drug repurposing for new, efficient, broad spectrum antivirals
por: García-Serradilla, Moisés, et al.
Publicado: (2019)

Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses
por: Ekins, Sean, et al.
Publicado: (2020)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

Broad-Spectrum Antivirals Derived from Natural Products
por: Tian, Wen-Jun, et al.
Publicado: (2023)

Near-Infrared Dyes: Towards Broad-Spectrum Antivirals
por: Mariewskaya, Kseniya A., et al.
Publicado: (2022)

Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)

Antidepressant Sertraline Is a Broad-Spectrum Inhibitor of Enteroviruses Targeting Viral Entry through Neutralization of Endolysosomal Acidification
por: Tseng, Kuan-Chi, et al.
Publicado: (2022)

Neuroprotective Effect of Chebulagic Acid via Autophagy Induction in SH-SY5Y Cells
por: Kim, Hee Ju, et al.
Publicado: (2014)

Pyrogallol, Corilagin and Chebulagic acid target the “fuzzy coat” of alpha-synuclein to inhibit the fibrillization of the protein
por: Bopardikar, Mandar, et al.
Publicado: (2022)

Antibiofilm effects of punicalagin against Staphylococcus aureus in vitro
por: Xu, Yunfeng, et al.
Publicado: (2023)

The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition
por: Goodier, John L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t9n8o8t1r0hmar7q6gg0cqe0n2